X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (63) 63
female (52) 52
breast cancer (50) 50
index medicus (50) 50
oncology (46) 46
aged (31) 31
middle aged (30) 30
chemotherapy (29) 29
breast neoplasms - drug therapy (28) 28
breast neoplasms - pathology (28) 28
cancer (26) 26
adult (23) 23
prognosis (18) 18
aged, 80 and over (17) 17
treatment outcome (17) 17
metastasis (15) 15
breast neoplasms - mortality (14) 14
patients (14) 14
breast (13) 13
breast neoplasms - surgery (13) 13
care and treatment (13) 13
survival (12) 12
tamoxifen (12) 12
tumors (12) 12
antineoplastic combined chemotherapy protocols - therapeutic use (11) 11
chemotherapy, adjuvant (11) 11
clinical trials (11) 11
disease-free survival (11) 11
retrospective studies (11) 11
antineoplastic agents, hormonal - therapeutic use (10) 10
research (10) 10
therapy (10) 10
erbb-2 protein (9) 9
metastases (9) 9
neoplasm metastasis (9) 9
surgery (9) 9
women (9) 9
abridged index medicus (8) 8
breast neoplasms - genetics (8) 8
carcinoma (8) 8
follow-up (8) 8
follow-up studies (8) 8
hematology, oncology and palliative medicine (8) 8
postmenopausal women (8) 8
tamoxifen - therapeutic use (8) 8
analysis (7) 7
antineoplastic agents - therapeutic use (7) 7
aromatase inhibitors - therapeutic use (7) 7
cancer therapies (7) 7
immunohistochemistry (7) 7
kaplan-meier estimate (7) 7
life sciences (7) 7
metastatic breast cancer (7) 7
neoplasm staging (7) 7
prospective studies (7) 7
randomized-trial (7) 7
receptor, erbb-2 - metabolism (7) 7
studies (7) 7
young adult (7) 7
breast neoplasms - chemistry (6) 6
cancer patients (6) 6
cyclophosphamide (6) 6
diagnosis (6) 6
double-blind (6) 6
elderly (6) 6
expression (6) 6
france (6) 6
letrozole (6) 6
medicine & public health (6) 6
patient outcomes (6) 6
product development (6) 6
proportional hazards models (6) 6
receptors, estrogen - analysis (6) 6
risk factors (6) 6
trastuzumab (6) 6
adjuvant treatment (5) 5
age factors (5) 5
antineoplastic combined chemotherapy protocols - adverse effects (5) 5
aromatase inhibitors (5) 5
breast neoplasms - diagnosis (5) 5
breast neoplasms - therapy (5) 5
double-blind method (5) 5
drug administration schedule (5) 5
hematology (5) 5
lymphatic metastasis (5) 5
magnetic resonance imaging (5) 5
mammography (5) 5
medical prognosis (5) 5
medical research (5) 5
neoplasm invasiveness (5) 5
nitriles - administration & dosage (5) 5
phase-iii (5) 5
predictive value of tests (5) 5
receptors, progesterone - analysis (5) 5
risk (5) 5
survival analysis (5) 5
tamoxifen - administration & dosage (5) 5
time factors (5) 5
triazoles - administration & dosage (5) 5
adjuvant chemotherapy (4) 4
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Lancet Oncology, The, ISSN 1470-2045, 2013, Volume 14, Issue 8, pp. 741 - 748
Summary Background Since 2005, 12 months of adjuvant trastuzumab has been the standard treatment for patients with HER2-positive early-stage breast cancer.... 
Hematology, Oncology and Palliative Medicine | ONCOLOGY | FOLLOW-UP | CHEMOTHERAPY | Breast Neoplasms - surgery | Predictive Value of Tests | Breast Neoplasms - secondary | Receptor, ErbB-2 - genetics | Humans | Middle Aged | Antineoplastic Combined Chemotherapy Protocols - adverse effects | Antineoplastic Agents - administration & dosage | Protein Kinase Inhibitors - adverse effects | Young Adult | Breast Neoplasms - chemistry | Antibodies, Monoclonal, Humanized - administration & dosage | Neoplasms, Second Primary | Time Factors | Antineoplastic Agents - adverse effects | Aged, 80 and over | Mastectomy | Adult | Female | Chemotherapy, Adjuvant | France | Heart Diseases - chemically induced | Radiotherapy, Adjuvant | Antibodies, Monoclonal, Humanized - adverse effects | Drug Administration Schedule | Early Detection of Cancer | Kaplan-Meier Estimate | Neoplasm Recurrence, Local | Proportional Hazards Models | Treatment Outcome | Breast Neoplasms - drug therapy | Disease-Free Survival | Protein Kinase Inhibitors - administration & dosage | Breast Neoplasms - genetics | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Breast Neoplasms - mortality | Aged | Infusions, Intravenous | Receptor, ErbB-2 - analysis | Trastuzumab | Antimitotic agents | Care and treatment | Clinical trials | Breast cancer | Product development | Antineoplastic agents | Cancer
Journal Article
Journal Article
The Lancet Oncology, ISSN 1470-2045, 10/2017, Volume 18, Issue 10, pp. 1360 - 1372
Journal Article
Journal Article
Journal Article
by Pivot, Xavier and Romieu, Gilles and Debled, Marc and Pierga, Jean-Yves and Kerbrat, Pierre and Bachelot, Thomas and Lortholary, Alain and Espié, Marc and Fumoleau, Pierre and Serin, Daniel and Jacquin, Jean-Philippe and Jouannaud, Christelle and Rios, Maria and Abadie-Lacourtoisie, Sophie and Venat-Bouvet, Laurence and Cany, Laurent and Catala, Stéphanie and Khayat, David and Gambotti, Laetitia and Pauporté, Iris and Faure-Mercier, Celine and Paget-Bailly, Sophie and Henriques, Julie and Grouin, Jean Marie and Piprot, C and Cals, L and Chaigneau, L and Demarchi, F and N'Guyen, T and Stein, U and Villanueva, C and Bréau, JL and Chouahnia, AK and Saintigny, P and Boué, F and deSaint-Hilaire, P and Guimont, I and Grossat, N and Valenza, B and Lévy, E and Médioni, J and Delbaldo, C and Grenier, J and Pouessel, D and Lavau-Denès, S and Falandry, C and Fournel-Fédérico, C and Freyer, G and Tartas, S and Trillet-Lenoir, V and Bons, F and Auclerc, G and Chièze, S and Raban, N and Tournigand, C and Trager-Maury, S and Bousquet, G and Cuvier, C and Giacchetti, S and Hocini, A and LeMaignan, C and Misset, JL and Avenin, D and Beerblock, C and Gligorov, J and Rivera, P and Roché, H and Bougnoux, P and Hajjaji, N and Capitain, O and Delva, R and Maillart, P and Soulié, P and Bonnefoi, H and Durand, M and Madranges, N and Mauriac, L and Chollet, P and Dillies, AF and Durando, X and Ferrière, JP and Mouret-Reynier, C and Nabholtz, JM and Van Praagh, I and Cottu, P and Diéras, V and Durieux, A and Galotte, M and Girre, V and Henry, S and Iurisci, I and Jouve, M and Laurence, V and Mignot, L and Piperno-Neumann, S and Tresca, P and Coudert, B and Ferrant, E and Mayer, F and Vanneuville, AC and ... and PHARE Trial Investigators and PHARE trial investigators
The Lancet, ISSN 0140-6736, 06/2019, Volume 393, Issue 10191, pp. 2591 - 2598
Journal Article
Journal Article
Breast Cancer Research and Treatment, ISSN 0167-6806, 1/2019, Volume 173, Issue 2, pp. 397 - 406
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 07/2018, Volume 379, Issue 2, pp. 122 - 137
Journal Article